Novo Nordisk says it will offer lower-priced Ozempic to some Canadian customers through a new savings program as generic versions of the diabetes and weight-loss drug enter the Canadian market.
Eligible Canadians without public or private drug coverage will be able to buy Ozempic for a lower price at pharmacies outside of Quebec using a savings card, the company said in a news release on May 26.
The move comes weeks after Canada became the first G7 country to approve generic versions of semaglutide, the active ingredient in Ozempic. The approval is expected to lower prices for one of the country’s most in-demand diabetes and weight-loss medications….